Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Alessandro Russo, Paolo Fusco, Helen Linda Morrone, Enrico Maria Trecarichi & Carlo Torti. (2023) New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Review of Anti-infective Therapy 21:1, pages 41-55.
Read now
Read now
Matteo Bassetti, Alessandro Russo, Alessia Carnelutti & Mark Wilcox. (2019) Emerging drugs for treating methicillin-resistant Staphylococcus aureus. Expert Opinion on Emerging Drugs 24:3, pages 191-204.
Read now
Read now
Daniele Roberto Giacobbe, Malgorzata Mikulska & Claudio Viscoli. (2018) Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria. Expert Review of Clinical Pharmacology 11:12, pages 1219-1236.
Read now
Read now
Jin-xin Zheng, Zhi-wei Lin, Xiang Sun, Wei-hong Lin, Zhong Chen, Yang Wu, Guo-bin Qi, Qi-wen Deng, Di Qu & Zhi-jian Yu. (2018) Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae. Emerging Microbes & Infections 7:1, pages 1-11.
Read now
Read now
Matteo Bassetti, Elda Righi, Alessia Carnelutti, Elena Graziano & Alessandro Russo. (2018) Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Review of Anti-infective Therapy 16:10, pages 749-761.
Read now
Read now
Matteo Bassetti, Alessandro Russo, Alessia Carnelutti, Alessandro La Rosa & Elda Righi. (2018) Antimicrobial resistance and treatment: an unmet clinical safety need. Expert Opinion on Drug Safety 17:7, pages 669-680.
Read now
Read now
Articles from other publishers (32)
Richie Rashmin Bhandare, Benjamin E. Blass & Daniel J. Canney. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
115
133
.
Bisma Jan, Rafia Jan, Suhaib Afzal, Mehrose Ayoub & Mubashir Hussain Masoodi. 2023. Non-traditional Approaches to Combat Antimicrobial Drug Resistance. Non-traditional Approaches to Combat Antimicrobial Drug Resistance
79
100
.
Sunil Kumar, Razique Anwer, Mukesh Yadav, Gourav Vats, Shivali Thakur, Nirmala Sehrawat, Vikas Kumar & Manoj Singh. (2022) An Update on Advancements in Treatment Options for Managing Klebsiella pneumoniae Infections. Current Pharmacology Reports 8:6, pages 439-449.
Crossref
Crossref
Christopher E. Morgan, Zhemin Zhang, Robert A. Bonomo & Edward W. Yu. (2022) An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii. mBio 13:1.
Crossref
Crossref
Irfan Ahmad Khan. 2022. Beta-Lactam Resistance in Gram-Negative Bacteria. Beta-Lactam Resistance in Gram-Negative Bacteria
287
298
.
Zhemin Zhang, Christopher E. Morgan, Robert A. Bonomo & Edward W. Yu. (2021) Cryo-EM Determination of Eravacycline-Bound Structures of the Ribosome and the Multidrug Efflux Pump AdeJ of Acinetobacter baumannii. mBio 12:3.
Crossref
Crossref
Matteo Bassetti, Elda Righi & Murat Akova. 2021. Infection Management in Hematology. Infection Management in Hematology
161
179
.
Yue Shi, Xiaoting Hua, Qingye Xu, Yunxing Yang, Linyue Zhang, Jintao He, Xinli Mu, Lihua Hu, Sebastian Leptihn & Yunsong Yu. (2020) Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC. Infection, Genetics and Evolution 80, pages 104185.
Crossref
Crossref
Ann A Elshamy & Khaled M Aboshanab. (2020) A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Science OA 6:3.
Crossref
Crossref
Yasunari Otsuka. (2020) Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria. Chemical and Pharmaceutical Bulletin 68:3, pages 182-190.
Crossref
Crossref
Ian Morrissey, Stephen Hawser, Sibylle H. Lob, James A. Karlowsky, Matteo Bassetti, G. Ralph Corey, Melanie Olesky, Joseph Newman & Corey Fyfe. (2020)
In Vitro
Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017
. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Crossref
Ian Morrissey, Melanie Olesky, Stephen Hawser, Sibylle H. Lob, James A. Karlowsky, G. Ralph Corey, Matteo Bassetti & Corey Fyfe. (2020)
In Vitro
Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Crossref
George G. Zhanel, Jenine Esquivel, Sheryl Zelenitsky, Courtney K. Lawrence, Heather J. Adam, Alyssa Golden, Rachel Hink, Liam Berry, Frank Schweizer, Michael A. Zhanel, Denice Bay, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Joseph P. LynchIIIIII & James A. Karlowsky. (2020) Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent. Drugs 80:3, pages 285-313.
Crossref
Crossref
Matthew W. McCarthy. (2019) Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline. Clinical Pharmacokinetics 58:9, pages 1149-1153.
Crossref
Crossref
Suay-García & Pérez-Gracia. (2019) Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections. Antibiotics 8:3, pages 122.
Crossref
Crossref
Anna Maria Peri, Yohei Doi, Brian A. Potoski, Patrick N.A. Harris, David L. Paterson & Elda Righi. (2019) Antimicrobial treatment challenges in the era of carbapenem resistance. Diagnostic Microbiology and Infectious Disease 94:4, pages 413-425.
Crossref
Crossref
Ilias Karaiskos, Styliani Lagou, Konstantinos Pontikis, Vasiliki Rapti & Garyphallia Poulakou. (2019) The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Frontiers in Public Health 7.
Crossref
Crossref
Matteo Bassetti, Elda Righi, Alessandro Russo & Alessia Carnelutti. (2018) New Antibiotics for Pneumonia. Clinics in Chest Medicine 39:4, pages 853-869.
Crossref
Crossref
Vidmantas Petraitis, Ruta Petraitiene, Bo Bo W. Maung, Farehin Khan, Ieva Alisauskaite, Melanie Olesky, Joseph Newman, Abdul Mutlib, Xiaoyun Niu, Michael Satlin, Ravi S. Singh, Harmut Derendorf & Thomas J. Walsh. (2018) Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
Adrian Brink. 2018. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill
73
99
.
H. Wright, R.A. Bonomo & D.L. Paterson. (2017) New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?. Clinical Microbiology and Infection 23:10, pages 704-712.
Crossref
Crossref
Matteo Bassetti & Elda Righi. 2017. Anti-infectives and the Lung. Anti-infectives and the Lung
1
20
.
L. Mayrink Assis, M. Nedeljković & A. Dessen. (2017) New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. Drug Resistance Updates 31, pages 1-14.
Crossref
Crossref
Shawn H. MacVane. (2016) Antimicrobial Resistance in the Intensive Care Unit. Journal of Intensive Care Medicine 32:1, pages 25-37.
Crossref
Crossref
Dana R. Bowers & Vanthida Huang. (2016) Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE). Current Infectious Disease Reports 18:12.
Crossref
Crossref
Dmitriy M. Martirosov & Thomas P. Lodise. (2016) Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae. Diagnostic Microbiology and Infectious Disease 85:2, pages 266-275.
Crossref
Crossref
Sebastiano Leone, Silvana Noviello & Silvano Esposito. (2015) Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci. Infection 44:3, pages 273-281.
Crossref
Crossref
Matteo Bassetti, Elda Righi & Alessia Carnelutti. (2016) New therapeutic options for respiratory tract infections. Current Opinion in Infectious Diseases 29:2, pages 178-186.
Crossref
Crossref
Ling-Shan Syue, Yen-Hsu Chen, Wen-Chien Ko & Po-Ren Hsueh. (2016) New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance. International Journal of Antimicrobial Agents 47:4, pages 250-258.
Crossref
Crossref
George G. Zhanel, Doris Cheung, Heather Adam, Sheryl Zelenitsky, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew Walkty, Alfred S. Gin, Daryl J. Hoban & James A. Karlowsky. (2016) Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent. Drugs 76:5, pages 567-588.
Crossref
Crossref
David Brown. (2015) Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?. Nature Reviews Drug Discovery 14:12, pages 821-832.
Crossref
Crossref
B. Clouzeau, A. Boyer, F. M’Zali, M. Kann & D. Gruson. (2015) Nouvelles stratégies thérapeutiques contre les entérobactéries productrices de β-lactamases à spectre étenduNew treatment strategies for extended-spectrum β-lactamase-producing enterobacteriaceae. Réanimation 24:3, pages 270-277.
Crossref
Crossref